Loading...
Images of Shigeyuki Chaki
(0 from 0 )Network Profiles
LinkedIn: Shigeyuki Chaki | LinkedIn
LinkedInは、Shigeyuki Chakiさんのような方が活動する世界最大のプロフェッショナルネットワークです。今すぐあなたも参加してビジネスの人脈や知識を広げましょう。
Loop | Shigeyuki Chaki
loop.frontiersin.org
Loop is the open research network that increases the discoverability and impact of researchers and their work. Loop enables you to stay up-to-date with the latest discoveries and news, connect with researchers and form new collaborations.
Interests
New type of depression identified: Protein linked with depression...
www.sciencedaily.com
Depression is a mental disorder that affects over 300 million people around the world. While treatments exist, many of them are based on one hypothesis of how...
Pharmacological Reports - Vol
rabbit.if-pan.krakow.pl
... II mGlu receptor antagonist, is serotonin- and GABA-dependent. Katarzyna Stachowicz, Joanna Wierońska, Helena Domin, Shigeyuki Chaki, Andrzej Pilc (p.
Business Profiles
Researchgate: Shigeyuki Chaki
Tokyo, Japan
patentbuddy: Shigeyuki Chaki
NIHON NOHYAKU CO., LTD.
Books & Literature
Tissue Renin-Angiotensin Systems: Current Concepts of Local ...books.google.com › books
books.google.de
... EXPRESSION AND REGULATION OF ANGIOTENSIN II RECEPTORS Tadashi Inagami, Yoshiaki Yamano, Smriti Bardhan, Shigeyuki Chaki, Deng-Fu Guo, ...
Biologie cellulaire et moléculaire du cortex surrénal - Google Books
books.google.de
Tadashi Inagami, Naoharu Iwai, Katsutoshi Sasaki, Yoshiaki Yamano, Smiriti Bardhan, Shigeyuki Chaki, Deng-Fu Guo, Hiroaki Furuta, Naomasa Makita and ...
Cellular and Molecular Biology of the Renin-Angiotensin System -...
books.google.de
Cellular and Molecular Biology of the Renin-Angiotensin System provides the first review and update of the state-of-the-art cellular and molecular aspects of...
Contemporary Aspects of Biomedical Research: Drug Discovery - Google...
books.google.de
Each volume of Advances in Pharmacology provides a rich collection of reviews on timely topics. Emphasis is placed on the molecular basis of drug action, both...
Related Documents
Metabotropic Glutamate Receptors: Potential Drug Targets for...
openmedicinalchemistryjournal.com
Metabotropic Glutamate Receptors: Potential Drug Targets for Psychiatric Disorders
Serotonin-1A receptor stimulation mediates effects of a metabotropic...
www.proquest.com
Kenichi Fukumoto & Michihiko Iijima & Shigeyuki Chaki. Received: 25 September Accepted: 25 November Published online:
Scientific Publications
Poster #S29 CEREBROSPINAL FLUID BIOMARKERS FOR SCHIZOPHRENIA REVEALED...
www.sciencedirect.com
Shigeyuki Chaki. x. Shigeyuki Chaki. Search for articles by this author. ,. Yasuyuki Fujii. x. Yasuyuki Fujii. Search for articles by this author. ,. Takao Yoshimizu.
Publications
IJMS | Free Full-Text | Role of Serotonergic System in the...
www.mdpi.com
Role of Serotonergic System in the Antidepressant Actions of mGlu2/3 Receptor Antagonists: Similarity to Ketamine. by Shigeyuki Chaki * and Kenichi Fukumoto.
An mGluR2/3 antagonist, MGS0039, exerts antidepressant and anxiolytic...
link.springer.com
Abnormalities of glutamatergic neurotransmission have been reportedly observed in psychiatric disorders. Previously, we demonstrated that (1R, 2R, 3R, 5R,
Efficacy of a glycine transporter 1 inhibitor TASP in animal...
link.springer.com
Efficacy of a glycine transporter 1 inhibitor TASP in animal models of cognitive dysfunction and negative symptoms of schizophrenia Shigeyuki Chaki …
MDPI - Publisher of Open Access Journals
www.mdpi.com
MDPI is a publisher of peer-reviewed, open access journals since its establishment in
Miscellaneous
Shigeyuki Chaki | LinkedIn
www.linkedin.com
View Shigeyuki Chaki’s professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Shigeyuki Chaki discover ...
WO A1 - Substituted imidazopyridine derivatives as...
patents.google.com
... a Novel and Potent Nonpeptide Antagonist of the Melanocortin-4 Receptor; Shigeyuki Chaki et al, J. Pharm. Exp. Ther. (2003) 304(2) ...
[PDF] Speaker 4: Shigeyuki Chaki, Japan | Semantic Scholar
www.semanticscholar.org
Background: Conventional antidepressant therapy has remained virtually unchanged for the past 50 years. The discovery of the rapid and potent antidepressant effects of the NMDA receptor antagonist ketamine has kindled interest in pursuing new and novel mechanisms for the treatment of depression. The cholinergic neurotransmitter system is implicated in affective illness, whereby a cholinergic ...
CHAPTER Drug Discovery for Psychiatric Disorders...
pubs.rsc.org
Shigeyuki Chaki and Kosuke Kanuma Print publication date: 02 Nov Copyright Year:2012 Print ISBN:
Altmetric – Activation of metabotropic glutamate 2/3 receptors...
springeropen.altmetric.com
Shigeyuki Chaki, Atsuro Nakazato, Hirotaka Onoe, Hitoshi Hashimoto, Akemichi
Baba, ...
Anxiolytic-Like and Antidepressant-Like Activities of MCL jpet.aspetjournals.org › content › tab-article-info
jpet.aspetjournals.org
Shigeyuki Chaki, Shiho Hirota, Takeo Funakoshi, Yoshiko Suzuki, Sayoko Suetake, Taketoshi Okubo, Takaaki Ishii, Atsuro Nakazato and Shigeru Okuyama .
Neurochemistry of the Nucleus Accumbens and its Relevance to...
www.eurekaselect.com
Neurochemistry of the Nucleus Accumbens and its Relevance to Depression and Antidepressant Action in Rodents Yukihiko Shirayama and Shigeyuki Chaki ...
MGlu2/3 and mGlu5 receptors: Potential targets for novel...
www.scholars.northwestern.edu
Shigeyuki Chaki, Yukio Ago, Agnieszka Palucha-Paniewiera, ...
Melanocortin-4 Receptor Antagonists for the Treatment of Depression...
www.eurekaselect.com
Derived from proopiomelanocortin by proteolytic processing, melanocortins have been implicated in a wide range of physiological processes. Melanocortins ex
High-Contrast PET Imaging of Vasopressin V1B Receptors with a Novel...
jnm.snmjournals.org
Kazumi Koga,,; Yuji Nagai,; Masayuki Hanyu,; Mitsukane Yoshinaga,; Shigeyuki Chaki,; Norikazu Ohtake,; Satoshi Ozaki,; Ming-Rong Zhang, ...
Melanin-concentrating hormone [MCH.sub.1] receptor antagonists: a...
go.gale.com
Gale Academic OneFile includes Melanin-concentrating hormone [MCH.sub.1] receptor anta by Toshiharu Shimazaki, Takao Yoshimizu, a. Click to explore.
Papers with the keyword MGlu2 novel targets depression | Read by QxMD
read.qxmd.com
Shigeyuki Chaki, Kenichi Fukumoto. Ever since the discovery of the rapid and
sustained ...
Targeting of Metabotropic Glutamate Receptors for the Treatment of...
www.eurekaselect.com
The glutamatergic system is involved in a wide range of physiological processes in the brain, and its dysfunction plays an important role in the ...
WFSBP Final Program - cpo-media.netwww.cpo-media.net › WFSBP › Final_Program › HTML
www.cpo-media.net
... Poland Co-Chair: Shigeyuki Chaki, Japan 001 mGlu5 receptors as a target for Post-traumatic Stress Disorder (PTSD) Carrie Jones, USA
Related search requests for Shigeyuki Chaki
| Kenichi Fukumoto |
People Forename "Shigeyuki" (109) Name "Chaki" (74) |
sorted by relevance / date